FibroGen Inc reports results for the quarter ended in June - Earnings Summary

Kyntra Bio

07/08/2023 22:02

* FibroGen Inc  FGEN.OQ  reported a quarterly adjusted loss
of 90
cents​​ per share for the quarter ended in June. The mean
expectation of six analysts for the quarter was for a loss of 70
cents per share.
    * Revenue rose 48.7% to $44.32 million from a year ago;
analysts
expected $34.74 million. 
    * FibroGen Inc's reported EPS for the quarter was a loss
of 90
cents​.
    * The mean earnings estimate of analysts had fallen by
about 1% in
the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * FibroGen Inc shares had fallen by 29.3% this quarter and
lost 88.1% so far this year.
    * The company reported a quarterly loss of $87.68 million.
    * Wall Street's median 12-month price target for FibroGen
Inc is
$4.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 6
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 7 at 09:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.70          -0.90          Missed
 Mar. 31 2023      -0.75          -0.81          Missed
 Dec. 31 2022      -0.94          -0.70          Beat
 Sep. 30 2022      -0.81          -0.98          Missed